CLOV Drops Becoming An Even More Affordable Buy

During the last session 10M of Clover Health Investments, Corp.’s (NasdaqGS:CLOV) shares were traded. The stock closed at $7.14 per share indicating that it lost -$0.33 or -4.42% during that day which brings the Clover Health Investments, Corp.’s valuation to $2.9B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -75.25% from that peak and close to a 52-week low of $6.31, while the S&P 500’s share price change was of 29%.

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen decay in its daily volume. The daily volume was of 29M, while in the last 10 days the average was 16.63M and last three months – 28.75M.


The decreasing interest in the CLOV stock from the investors is helping to drive the stock price down.

Growing short interest

The Clover Health Investments, Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 40.46M shares being shorted which translates into 1.07 of a short ratio for CLOV, while in the previous month the shorted shares were 38.7M.

Advertisements

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of 2.9B, Clover Health Investments, Corp. holds a total cash of $684.57M that translates into $1.68 per share, while the total debt is of $55.94M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 18.00%. The current revenue is of $720.55M that is $6.27 per share.


This is a great sign for a bright future.